Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation

Abstract

Despite having more steatosis and inflammation, progression of fibrosis was slower in NASH compared with ALD recipients. Fibrosis progression slows with time following LT on immunosuppression and approximates the pretransplant progression rate by year 5.